# Routine Use of Medicinal Cannabis: Risks and Clinical Standards

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/clinical-standards-cannabis-medicine-risks-routine-use/
> **Published:** 2026-03-21T16:02:15-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:42:22-04:00
> **Clinical Summary:** Explore clinical standards cannabis medicine and why routine use of medicinal cannabis could pose risks without proper guidelines and patient safety measures.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Clinical StandardsPatient SafetyPrescribing GuidelinesEvidence-Based Medicine[Healthcare Policy](https://cedclinic.com/cannabis-legalization-in-canada-new-opportunities/)

Why This Matters

This headline reflects ongoing tensions in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) between emerging clinical evidence and established treatment paradigms. Clinicians need clear guidance on when [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) is appropriate versus when conventional treatments remain first-line, particularly as patient demand often outpaces evidence quality.

Clinical Summary
Without access to the full study details, this appears to address concerns about indiscriminate cannabis prescribing potentially displacing proven therapies or creating unnecessary risks. The Australian medical context suggests scrutiny of their Special Access Scheme prescribing patterns. Such concerns typically center on inadequate patient selection, insufficient monitoring protocols, or displacement of evidence-based treatments for conditions where cannabis evidence remains limited.

Dr. Caplan’s Take

“Headlines like this underscore why rigorous patient selection and outcome monitoring are non-negotiable in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). We cannot allow enthusiasm for this therapeutic option to compromise clinical standards or patient safety.”

Clinical Perspective
🧠 Clinicians should maintain strict evidence-based prescribing criteria, ensure comprehensive patient evaluation before [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), and implement systematic follow-up protocols. This reinforces the importance of treating [cannabis as medicine](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) requiring the same clinical rigor as any pharmaceutical intervention, not as a universally safe alternative therapy.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20%27Routine%20use%20of%20medicinal%20cannabis%20could%20be%20doing%20more%20harm%20than%20good%27%20%7C%20AJP%20%40drcaplan&url=https%3A//ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20%27Routine%20use%20of%20medicinal%20cannabis%20could%20be%20doing%20more%20harm%20than%20good%27%20%7C%20AJP%20--%20via%20%40drcaplan.bsky.social%20https%3A//ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/](https://ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/)

Table of Contents

- [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system)
- [What type of clinical standards does this relate to?](#What_type_of_clinical_standards_does_this_relate_to)
- [Why is this classified as “Notable Clinical Interest”?](#Why_is_this_classified_as_8220Notable_Clinical_Interest8221)
- [What aspects of patient safety are being addressed?](#What_aspects_of_patient_safety_are_being_addressed)
- [How does this relate to current prescribing practices?](#How_does_this_relate_to_current_prescribing_practices)
- [Related](#Related)

## FAQ

#### What is the CED Clinical Relevance rating system?

The CED Clinical Relevance system appears to be a classification method that rates clinical findings and developments. This particular item received a rating of #70 with “Notable Clinical Interest,” indicating emerging findings or policy developments that warrant close monitoring by healthcare professionals.

#### What type of clinical standards does this relate to?

This relates to clinical standards in cannabis medicine, specifically focusing on patient safety protocols and prescribing guidelines. The emphasis is on evidence-based medicine practices for cannabis therapeutics.

#### Why is this classified as “Notable Clinical Interest”?

Items with this classification represent emerging findings or policy developments in cannabis medicine that are worth monitoring closely. These developments may have potential implications for clinical practice or patient care protocols.

#### What aspects of patient safety are being addressed?

The focus appears to be on establishing proper prescribing guidelines and clinical standards for [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). This includes implementing evidence-based protocols to ensure safe and effective patient care in cannabis medicine.

#### How does this relate to current prescribing practices?

This development likely involves updates or new guidelines for healthcare providers prescribing cannabis-based medications. The emphasis on evidence-based medicine suggests a move toward more standardized, research-supported prescribing protocols in cannabis therapeutics.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “‘Routine use of medicinal cannabis could be doing more harm than good’ | AJP”, “url”: “https://ajp.com.au/news/routine-use-of-medicinal-cannabis-could-be-doing-more-harm-than-good/”, “datePublished”: “2026-03-21T16:06:27Z”, “about”: “routine use medicinal cannabis could doing”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[The Wild West of medicinal cannabis prescriptions – i Newspaper](https://cedclinic.com/medicinal-cannabis-prescribing-standards-patient-safety/)

Explore the challenges and inconsistencies in medicinal cannabis prescribing practices and the need for standardized clinical guidelines.

[Read More](https://cedclinic.com/medicinal-cannabis-prescribing-standards-patient-safety/)

[Medicinal Cannabis no better than placebo for some mental health conditions – ABC listen](https://cedclinic.com/placebo-effect-cannabis-mental-health-study/)

Review evidence highlighting limited benefits of medicinal cannabis for certain mental health conditions, emphasizing the importance of clinical standards.

[Learn More](https://cedclinic.com/placebo-effect-cannabis-mental-health-study/)

[Will medicinal cannabis help my mental health? Here are the evidence and the risks](https://cedclinic.com/medicinal-cannabis-demand-mental-health-soars-evidence-risks/)

An educational overview of the evidence and risks associated with medicinal cannabis use for mental health, underscoring the need for evidence-based prescribing.

[Explore Now](https://cedclinic.com/medicinal-cannabis-demand-mental-health-soars-evidence-risks/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
